Difficulty: Medium
Average Score: 65%
Practice
Atypical hemolytic-uremic syndrome may be triggered by
Correct answer
D
Rationale
Atypical hemolytic-uremic syndrome (aHUS) is a rare but serious condition characterized by the triad of microangiopathic hemolytic anemia, thrombocytopenia, and acute kidney injury. Cyclosporine, option D, is the correct answer as a trigger for aHUS. Cyclosporine is an immunosuppressant drug commonly used in transplant recipients to prevent organ rejection. It has been associated with the development of aHUS due to its potential to cause endothelial cell damage, leading to the activation of the complement system and subsequent hemolysis.
Option A, toxin-producing E. coli, is a common cause of typical (infectious) HUS in children, but not typically associated with aHUS. Option B, raw milk, is a potential source of E. coli infection but is not a direct trigger for aHUS. Option C, Streptococcus pneumoniae, is associated with another form of HUS known as pneumococcal HUS, which is different from aHUS triggered by cyclosporine.
In an educational context, understanding the triggers and pathophysiology of aHUS is crucial for healthcare professionals caring for pediatric patients. By knowing that medications like cyclosporine can induce aHUS, providers can monitor patients for early signs and symptoms, leading to prompt diagnosis and appropriate management. This knowledge can potentially prevent serious complications associated with aHUS.
Option A, toxin-producing E. coli, is a common cause of typical (infectious) HUS in children, but not typically associated with aHUS. Option B, raw milk, is a potential source of E. coli infection but is not a direct trigger for aHUS. Option C, Streptococcus pneumoniae, is associated with another form of HUS known as pneumococcal HUS, which is different from aHUS triggered by cyclosporine.
In an educational context, understanding the triggers and pathophysiology of aHUS is crucial for healthcare professionals caring for pediatric patients. By knowing that medications like cyclosporine can induce aHUS, providers can monitor patients for early signs and symptoms, leading to prompt diagnosis and appropriate management. This knowledge can potentially prevent serious complications associated with aHUS.